FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018538802> ?p ?o ?g. }

• W2018538802 endingPage "818" @default.
• W2018538802 startingPage "811" @default.
• W2018538802 abstract "Monoclonal antibodies against tumour-associated antigens could be useful to deliver enzymes selectively to the site of a tumour for activation of a non-toxic prodrug. A completely human fusion protein may be advantageous for repeated administration, as host immune responses may be avoided. We have constructed a fusion protein consisting of a human single chain Fv antibody, C28, against the epithelial cell adhesion molecule and the human enzyme β-glucuronidase. The sequences encoding C28 and human enzyme β-glucuronidase were joined by a sequence encoding a flexible linker, and were preceded by the IgGκ signal sequence for secretion of the fusion protein. A CHO cell line was engineered to secrete C28-β-glucuronidase fusion protein. Antibody specificity and enzyme activity were retained in the secreted fusion protein that had an apparent molecular mass of 100 kDa under denaturing conditions. The fusion protein was able to convert a non-toxic prodrug of doxorubicin, N-[4-doxorubicin-N-carbonyl(oxymethyl)phenyl]-O-β-glucuronyl carbamate to doxorubicin, resulting in cytotoxicity. A bystander effect was demonstrated, as doxorubicin was detected in all cells after N-[4-doxorubicin-N-carbonyl(oxymethyl)phenyl]-O-β-glucuronyl carbamate administration when only 10% of the cells expressed the fusion protein. This is the first fully human and functional fusion protein consisting of an scFv against epithelial cell adhesion molecule and human enzyme β-glucuronidase for future use in tumour-specific activation of a non-toxic glucuronide prodrug." @default.
• W2018538802 created "2016-06-24" @default.
• W2018538802 creator A5021729725 @default.
• W2018538802 creator A5026264825 @default.
• W2018538802 creator A5033586033 @default.
• W2018538802 creator A5059098786 @default.
• W2018538802 creator A5070095269 @default.
• W2018538802 creator A5073129226 @default.
• W2018538802 creator A5077571124 @default.
• W2018538802 creator A5088663155 @default.
• W2018538802 date "2002-02-26" @default.
• W2018538802 modified "2023-10-15" @default.
• W2018538802 title "A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug" @default.
• W2018538802 cites W1502767888 @default.
• W2018538802 cites W1877082552 @default.
• W2018538802 cites W1915689252 @default.
• W2018538802 cites W1965348791 @default.
• W2018538802 cites W1981793850 @default.
• W2018538802 cites W1983748607 @default.
• W2018538802 cites W1993759349 @default.
• W2018538802 cites W2003977399 @default.
• W2018538802 cites W2011729980 @default.
• W2018538802 cites W2018289835 @default.
• W2018538802 cites W2027237423 @default.
• W2018538802 cites W2029925637 @default.
• W2018538802 cites W2041375044 @default.
• W2018538802 cites W2041623801 @default.
• W2018538802 cites W2050314327 @default.
• W2018538802 cites W2067515443 @default.
• W2018538802 cites W2096743918 @default.
• W2018538802 cites W2098255750 @default.
• W2018538802 cites W2100837269 @default.
• W2018538802 cites W2101585839 @default.
• W2018538802 cites W2108247477 @default.
• W2018538802 cites W2134640618 @default.
• W2018538802 cites W2143088883 @default.
• W2018538802 cites W2154027407 @default.
• W2018538802 cites W2155392902 @default.
• W2018538802 cites W2169693919 @default.
• W2018538802 cites W2280071310 @default.
• W2018538802 cites W2319203375 @default.
• W2018538802 cites W2319558635 @default.
• W2018538802 cites W2327310363 @default.
• W2018538802 cites W2402287483 @default.
• W2018538802 cites W68282923 @default.
• W2018538802 cites W2418702086 @default.
• W2018538802 doi "https://doi.org/10.1038/sj.bjc.6600143" @default.
• W2018538802 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2375299" @default.
• W2018538802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11875747" @default.
• W2018538802 hasPublicationYear "2002" @default.
• W2018538802 type Work @default.
• W2018538802 sameAs 2018538802 @default.
• W2018538802 citedByCount "31" @default.
• W2018538802 countsByYear W20185388022012 @default.
• W2018538802 countsByYear W20185388022013 @default.
• W2018538802 countsByYear W20185388022014 @default.
• W2018538802 countsByYear W20185388022015 @default.
• W2018538802 countsByYear W20185388022016 @default.
• W2018538802 countsByYear W20185388022017 @default.
• W2018538802 countsByYear W20185388022022 @default.
• W2018538802 crossrefType "journal-article" @default.
• W2018538802 hasAuthorship W2018538802A5021729725 @default.
• W2018538802 hasAuthorship W2018538802A5026264825 @default.
• W2018538802 hasAuthorship W2018538802A5033586033 @default.
• W2018538802 hasAuthorship W2018538802A5059098786 @default.
• W2018538802 hasAuthorship W2018538802A5070095269 @default.
• W2018538802 hasAuthorship W2018538802A5073129226 @default.
• W2018538802 hasAuthorship W2018538802A5077571124 @default.
• W2018538802 hasAuthorship W2018538802A5088663155 @default.
• W2018538802 hasBestOaLocation W20185388021 @default.
• W2018538802 hasConcept C104317684 @default.
• W2018538802 hasConcept C108215921 @default.
• W2018538802 hasConcept C123894998 @default.
• W2018538802 hasConcept C153911025 @default.
• W2018538802 hasConcept C159654299 @default.
• W2018538802 hasConcept C185592680 @default.
• W2018538802 hasConcept C203014093 @default.
• W2018538802 hasConcept C2776694085 @default.
• W2018538802 hasConcept C2778556491 @default.
• W2018538802 hasConcept C2781303535 @default.
• W2018538802 hasConcept C40767141 @default.
• W2018538802 hasConcept C542903549 @default.
• W2018538802 hasConcept C54355233 @default.
• W2018538802 hasConcept C55493867 @default.
• W2018538802 hasConcept C86803240 @default.
• W2018538802 hasConceptScore W2018538802C104317684 @default.
• W2018538802 hasConceptScore W2018538802C108215921 @default.
• W2018538802 hasConceptScore W2018538802C123894998 @default.
• W2018538802 hasConceptScore W2018538802C153911025 @default.
• W2018538802 hasConceptScore W2018538802C159654299 @default.
• W2018538802 hasConceptScore W2018538802C185592680 @default.
• W2018538802 hasConceptScore W2018538802C203014093 @default.
• W2018538802 hasConceptScore W2018538802C2776694085 @default.
• W2018538802 hasConceptScore W2018538802C2778556491 @default.
• W2018538802 hasConceptScore W2018538802C2781303535 @default.
• W2018538802 hasConceptScore W2018538802C40767141 @default.
• W2018538802 hasConceptScore W2018538802C542903549 @default.
• W2018538802 hasConceptScore W2018538802C54355233 @default.

• next